A recent study found that krill oil may have neuroprotective qualities that slow down hallmarks of aging.
A recent study published in the journal Aging1 found that krill oil may have neuroprotective qualities that slow down hallmarks of aging.
“There is no question that we need more science to understand how we can impact and improve the life quality of an aging population,” said Line Johnsen, vice president, science and innovation, for Aker BioMarine, in a press release. “We have invested in a new study that looks at how krill oil can influence many underlying mechanisms that contribute to aging.”
In the study, researchers used a Caenorhabditis elegans model of Parkinson’s disease which found that krill oil provided by Aker BioMarine protected dopaminergic neurons from aging-related degeneration, decreased alpha-synuclein aggregation, and improved dopamine-dependent behavior and cognition. According to the researchers, “Krill oil rewires distinct gene expression programs that contribute to attenuating several aging hallmarks, including oxidative stress, proteotoxic stress, senescence, genomic instability, and mitochondrial dysfunction. Mechanistically, krill oil increases neuronal resilience through temporal transcriptome rewiring to promote anti-oxidative stress and anti-inflammation via healthspan regulating transcription factors such as SNK-1.”
Reference
SenGupta T et al. “Krill oil protects dopaminergic neurons from age-related degeneration through temporal transcriptome rewiring and suppression of several hallmarks of aging.” Aging, vol. 9, no. 21 (2022): 8661-8687, https://doi.org/10.18632/aging.204375
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.